GILEAD SCIENCES, INC. — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-01-04

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	Common Stock	M	823	$26.99	Acquired	49606	Direct
2016-01-04	Common Stock	M	1177	$24.905	Acquired	50783	Direct
2016-01-04	Common Stock	S	2000	$99.20	Disposed	48783	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Non-Qualified Stock Option (right to buy)	$24.905	M	1177	Disposed	2019-07-29	Common Stock (1177)	Direct
2016-01-04	Non-Qualified Stock Option (right to buy)	$26.99	M	823	Disposed	2018-07-30	Common Stock (823)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.